Alpha DNA Investment Management »

Vertex Pharmaceuticals Incorporated shares owned by Alpha DNA Investment Management

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Alpha DNA Investment Management from 13F filings

Historical chart of Alpha DNA Investment Management investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Alpha DNA Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Alpha DNA Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $792k 1.9k 406.89
2022-12-31 $1.3M 4.6k 288.78
2021-03-31 $54k 252 214.29
2020-12-31 $64k 271 236.16

More positions owned by Alpha DNA Investment Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Microsoft Corporation (MSFT)
JPMorgan Chase & Co. (JPM)
Wells Fargo & Company (WFC)
Wal-Mart Stores (WMT)
Chevron Corporation (CVX)
EOG Resources (EOG)
Nextera Energy (NEE)
Cisco Systems (CSCO)
Chubb (CB)
Abbvie (ABBV)
Apple (AAPL)
Charles Schwab Corporation (SCHW)
Bank of America Corporation (BAC)

View all positions for Alpha DNA Investment Management

Top funds holding Vertex Pharmaceuticals Incorporated

Vanguard Group
Alliancebernstein
T. Rowe Price Associates
Jpmorgan Chase & Co
Wellington Management Company
Jennison Associates
Massachusetts Financial Services
Norges Bank Investment Management
Amundi
Bank of America Corporation
Ubs Global Asset Management Americas
ClearBridge Advisors
Legal & General Group
Henderson Group
Bank of New York Mellon

View all funds holding Vertex Pharmaceuticals Incorporated